Cetuximab: all 645 studies that test it

Page 7 of 7. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.

• Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00227734Phase 2
• XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal CancerStatus unknownNCT00215722Phase 2
• An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal CancerCompletedNCT00207155Phase 1
• An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung CarcinomaCompletedNCT00207116Phase 1
• Study of Cetuximab in Combination With Tarceva in Patients With Solid TumorsCompletedNCT00207077Phase 1
• BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal MalignanciesCompletedNCT00207051Phase 1
• Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal CancerCompletedNCT00202787Phase 2
• Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00182715Phase 3
• Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx PreservationCompletedNCT00169247Phase 2
• Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal CancerCompletedNCT00165490Phase 2
• Cetuximab and Vinorelbine in Elderly Subjects With Lung CancerCompletedNCT00165334Phase 2
• A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedNCT00162318Phase 1
• A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal SurfacesCompletedNCT00162110Phase 2
• Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)CompletedNCT00153998Phase 2
• Cetuximab in Patients With Unresectable or Metastatic Hepatocellular CarcinomaCompletedNCT00142428Phase 2
• Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00134069Phase 1
• Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00118183Phase 2
• Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00115518Phase 2
• Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedNCT00112346Phase 2
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerCompletedNCT00104910Phase 1
• Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00101348Phase 1/2
• Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00097227Phase 2
• Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00097214Phase 2
• Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00086892Phase 2
• S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00085501Phase 2
• Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal CancerCompletedNCT00084773Not applicable
• A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal CarcinomaTerminatedNCT00082212Phase 2
• Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung CancerCompletedNCT00081302Phase 2
• Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal CancerCompletedNCT00079066Phase 3
• FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or RectumTerminatedNCT00077233Phase 3
• S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas CancerCompletedNCT00075686Phase 3
• Phase II Study in Patients With Recurrent Non-Small-Cell Lung CancerCompletedNCT00063388Phase 2
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal CancerCompletedNCT00063141Phase 3
• Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal CancerCompletedNCT00061815Phase 3
• Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00056030Phase 2
• A Study of Cetuximab in Patients Who Have Stage IV Colorectal CancerCompletedNCT00055419Phase 2
• Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal CarcinomaCompletedNCT00044863Phase 2
• Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung CancerCompletedNCT00034541Phase 1/2
• Cetuximab in Treating Patients With Stage IV Colorectal CancerCompletedNCT00020930Phase 2
• Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal CancerCompletedNCT00020917Phase 2
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck CancerCompletedNCT00005814Phase 2
• Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the PancreasWithdrawnNCT00005591Phase 2
• Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal CancerCompletedNCT00005076Phase 2
• Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin ChemotherapyCompletedNCT00004865Phase 2
• Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or LarynxTerminatedNCT00004227Phase 3

← Cetuximab overview